FDA: Diabetes drug possibly linked to cancer

September 17, 2010 2:25:33 PM PDT
The FDA says it is reviewing data suggesting a possible link between the diabetes drug Actos and bladder cancer.The agency says five-year results from an on-going study show patients taking Actos the longest had higher risks of bladder cancer.

Sales of Actos have surged in recent years because it is seen as a safer alternative to Avandia.

The FDA is considering withdrawing Avandia because of potential heart risks.